BeOne Medicines Ltd. - Sponsored ADR (ONC)
(Delayed Data from NSDQ)
$307.23 USD
+2.93 (0.96%)
Updated Aug 5, 2025 04:00 PM ET
After-Market: $307.35 +0.12 (0.04%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth A Momentum B VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
ONC 307.23 +2.93(0.96%)
Will ONC be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for ONC based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ONC
Stevanato (STVN) Soars 10.0%: Is Further Upside Left in the Stock?
BeOne Medicines Ltd. - Sponsored ADR (ONC) Surges 4.0%: Is This an Indication of Further Gains?
ONC: What are Zacks experts saying now?
Zacks Private Portfolio Services
Compared to Estimates, BeiGene (ONC) Q1 Earnings: A Look at Key Metrics
Community Health Q1 Earnings Top on Rising Patient Volumes, Stock Up 8%
Universal Health Q1 Earnings Beat on Strong Acute Care Admissions
Other News for ONC
BeiGene's Earnings: A Preview
BeiGene Q2 2025 Earnings Preview
Here are the major earnings before the open Wednesday
BeOne Medicines (ONC) Secures EMA PRIME Designation for BGB-16673
BeOne Medicines Receives PRIME Designation from the European Medicines Agency for BGB-16673 in ...